We have been instructed by a New York law firm to represent the Borrower in a US$500,000,000 transaction for the takeover and the business combination and refinancing of a group of pharmaceutical companies in the US.
We have been instructed by a New York law firm to represent the Borrower in a US$500,000,000 transaction for the takeover and the business combination and refinancing of a group of pharmaceutical companies in the US.